REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
7.62
+0.21 (2.83%)
At close: Dec 20, 2024, 4:00 PM
7.71
+0.09 (1.18%)
After-hours: Dec 20, 2024, 7:01 PM EST
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $377.53 million as of December 20, 2024. Its market cap has decreased by -58.34% in one year.
Market Cap
377.53M
Enterprise Value
244.78M
1-Year Change
-58.34%
Ranking
Category
Stock Price
$7.62
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $377.53M, a decrease of -49.62%. That is a compound annual growth rate of -7.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 377.50M | -52.20% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 384.13M |
| Alpha Teknova | 383.02M |
| GH Research | 380.59M |
| ZimVie | 373.92M |
| Jupiter Neurosciences | 372.14M |
| Personalis | 368.08M |
| Delcath Systems | 360.66M |
| Prime Medicine | 359.82M |